Equine Rhinitis B Virus Detected with Increasing Frequency
Spring 2024: Equine rhinitis B virus (ERBV) is recognized for its impact on the respiratory health of horses, with three distinct serotypes identified: ERBV1, ERBV2 and ERBV3.
Spring 2024: Equine rhinitis B virus (ERBV) is recognized for its impact on the respiratory health of horses, with three distinct serotypes identified: ERBV1, ERBV2 and ERBV3.
Fall 2023: Findings document disease trends and emphasize importance of pathogen identification in early management of outbreaks.
Spring 2023: In the last issue (Fall 2022) of this newsletter, a rising trend in S. equi cases was reported. That trajectory has continued through the most recent 6-month reporting period.
Winter 2022: Equine influenza and equine herpesvirus type 4 are the two most prevalent viruses
Spring 2022: Two practitioners share their approach to managing a Streptococcus equi diagnosis
Fall 2021: Program’s 10,000th sample arrives and most recent six-month respiratory disease trends. Plus, new series on the ins and outs of vaccination protocols.
Spring 2020: Follow one practitioner’s infectious upper respiratory disease case journey.
Spring 2015: The inaugural issue of the Equine Respiratory Update newsletter provides an overview of the Equine Biosurveillance Program, developed to study the prevalence and epidemiology of relevant viral and bacterial respiratory pathogens.
Spring 2019: Infectious respiratory disease trends in the industry, from influenza and equine herpesvirus to strangles.
Fall 2018: Biosurveillance Program sheds light on Streptococcus equi subs. equi (better known as strangles), prevalence factors.